000788 董事长被刑事拘留！

Core Viewpoint - The chairman and president of Beijing University Pharmaceutical (北大医药), Xu Xiren, has been criminally detained, affecting his ability to perform his duties, while the company's control and operations remain stable [2][6]. Group 1: Management Changes - Xu Xiren has temporarily delegated his responsibilities to board member Chen Yuezhong and executive vice president Yu Mengchuan due to personal reasons [5]. - The delegation of authority is effective from the date of the written authorization and will remain in effect until Xu Xiren provides written notice to terminate it [5]. Group 2: Company Operations - As of the announcement date, the company has stated that its control has not changed, the board is functioning normally, and its financial and operational management is stable [2][6]. - The company is currently unaware of the progress or conclusions of the investigation into Xu Xiren's detention [6]. Group 3: Financial Impact - Following Xu Xiren's leadership, the company has faced challenges, including the termination of a long-term service contract with Beijing University International Hospital, which is expected to reduce sales revenue by approximately 600 million yuan and net profit by about 40 million yuan in 2025 [7]. - The company anticipates a revenue decrease of approximately 1.027 billion yuan starting in 2026, which is about 49.85% of the 2024 revenue [7].